Clinical Trials
139 trialsLS301-IT in Partial Mastectomy and Sentinel Lymph Node Biopsy (SLNB) for DCIS or Stage I-II Primary Invasive Breast Cancer
Integro Theranostics
MRI in Assessing Tumor Size in Women With Ductal Carcinoma In Situ
Centre Antoine Lacassagne
TBCRC042
Baylor Breast Care Center
Demographics, Characteristics and Outcomes of Male Breast Cancer Patients at Methodist Health System
Methodist Health System
Babytam long
Ente Ospedaliero Ospedali Galliera
THRIVE
University of Colorado, Boulder
Abbreviated Breast MRI After Cancer Treatment
University of Pennsylvania
NOVEMBER
University of Utah
Intraoperative Gamma Camera for Breast Cancer Surgery
University Hospital, Strasbourg, France
CINNAMOME
Institut Bergonié
NAVIMOZ
AC Camargo Cancer Center
Studying Blood and Tumor Tissue Samples in Women With Invasive Breast Cancer, Ductal or Lobular Carcinoma in Situ, or Benign Breast Disease
City of Hope Medical Center
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy
National Cancer Institute (NCI)
CAREFOR
Thomas Jefferson University
EMBr Wave for the Reduction of Hot Flashes in Women With a History of Breast Cancer
Ohio State University Comprehensive Cancer Center
Breast MRI as a Preoperative Tool for DCIS
Memorial Sloan Kettering Cancer Center
An Episodic Future Thinking Intervention to Promote Weight Loss in Breast Cancer Survivors
Ohio State University Comprehensive Cancer Center
The PROMISE Study: Duavee in Women With DCIS
Northwestern University
POSTBOx
University of Warwick
The Use of Deep Inspiration Breath Hold and Prone Irradiation to Decrease Cardiac Radiation Exposure
Medical College of Wisconsin
Testing an Active Form of Tamoxifen (4-hydroxytamoxifen) Delivered Through Breast Skin to Control Ductal Carcinoma in Situ (DCIS) of the Breast
Northwestern University
IBIS-II DCIS
Queen Mary University of London
Assessing the Impact of the Microbiome on Breast Cancer Radiotherapy Toxicity
Case Comprehensive Cancer Center
Contrast-Enhanced MRI for the Characterization of Ductal Carcinoma in Situ (DCIS)
University of California, San Francisco
Effect of Aromatase Inhibitor Therapy on Blood Vessel Function in Postmenopausal Women With Breast Cancer
Mayo Clinic
Nelipepimut-S Plus GM-CSF Vaccine Therapy in Treating Patients With Breast Cancer
National Cancer Institute (NCI)
Abbreviated MRI Protocol: Initial Experience With Dotarem® (Gadoterate Meglumine)
University of Chicago
Breast-Conserving Surgery and Radiation Therapy in Patients With Multiple Ipsilateral Breast Cancer
Alliance for Clinical Trials in Oncology
Soy Isoflavones Supplementation in Treating Women at High Risk For or With Breast Cancer
University of Southern California
A Pilot Pre-operative Window Trial of Black Cohosh in Women With Ductal Carcinoma in Situ
Yale University
BCCR
University of Nebraska
Effect of Tamoxifen or an Aromatase Inhibitor on Estrogen Metabolism in Women Treated for Newly Diagnosed Breast Cancer
University of Nebraska
Study of Urine Samples From Women With Newly Diagnosed Breast Cancer Enrolled on Clinical Trial UNMC-08105
University of Nebraska
OPAR
Ontario Clinical Oncology Group (OCOG)
Effect of PACK Health Support Program on Patient Reported Outcomes in Patients With Breast Cancer
M.D. Anderson Cancer Center
Selective Omission of Sentinel Lymph Node Biopsy in Mastectomy for Ductal Carcinoma in Situ: Identifying Eligible Candidates
Gangnam Severance Hospital
The Breast Duct: Pilot Study of Genomic Sequencing of Exfoliated Ductal Cells Obtained Through Endoscopy and Lavage
Atossa Therapeutics, Inc.
TRIUMPH-T
Rutgers, The State University of New Jersey
Genetic Susceptibility to Radiation-Induced Skin Reactions in Racial/Ethnic Groups of Patients With Breast Cancer
Wake Forest University Health Sciences
Transdermal or Oral Telapristone Acetate in Treating Patients Undergoing Mastectomy
Northwestern University
A Prospective Trial to Compare Deep Inspiratory Breath Hold (DIBH) With Prone Breast Irradiation
NYU Langone Health
The Ultrasound-guided Multiple-injection Costotransverse Block for Mastectomy and Primary Reconstructive Surgery.
Zealand University Hospital
Acceptability of Active Monitoring (AM) as a Treatment Option for Ductal Carcinoma in Situ (DCIS)
Duke University
Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer
National Cancer Institute (NCI)
Pilot Study of a an App to Improve Medication Adherence in Breast Cancer Survivors Receiving AIs
Indiana University
Radiation Therapy in Treating Women With Locally Recurrent Breast Cancer Previously Treated With Repeat Breast-Preserving Surgery
Radiation Therapy Oncology Group
Radiation Therapy With or Without Optional Tamoxifen in Treating Women With Ductal Carcinoma in Situ
Radiation Therapy Oncology Group
Radiation Therapy (WBI Versus PBI) in Treating Women Who Have Undergone Surgery For Ductal Carcinoma In Situ or Stage I or Stage II Breast Cancer
NSABP Foundation Inc
BrUOG 291: Five Fraction Partial Breast Irradiation Using Non-invasive Image-guided Breast Brachytherapy (NIBB)
Brown University
SPrNSM
University of Texas Southwestern Medical Center